CIM
MED icon

Cambria Investment Management’s Medifast MED Stock Holding History

Cambria Investment Management’s Portfolio MED Stock Details MED Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q4 		– Sell
-68,200
Closed -$1.83M – 231
2015
Q3 		$1.83M Sell
68,200
-17,197
-20% -$501K 0.71% 45
2015
Q2 		$2.76M Buy
85,397
+593
+0.7% +$18.8K 0.84% 27
2015
Q1 		$2.54K Buy
84,804
+4,151
+5% +$132K 0.29% 45
2014
Q4 		$2.71M Buy
+80,653
New +$2.51M 0.97% 17

Other funds holding MED

VAM
Visium Asset Management New York $1.43B AUM 3.58% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
EC
Engaged Capital Newport Beach, California $303M AUM 2.09% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
NI
Numeric Investors Boston, Massachusetts $13.7B AUM 28.88% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Cambria Investment Management's MED Position: Q4 2015 in Review

Cambria Investment Management sold out of Medifast (MED) in Q4 2015, closing a stake of 68,200 shares — an estimated $1.83M sold.

Cambria Investment Management first reported a position in MED in Q4 2014 and held it in 4 quarters. The position peaked at $2.76M in Q2 2015. 131 funds tracked by Wall St. Rank hold MED as of Q4 2015.

  • Cambria Investment Management reported no remaining Medifast position as of Q4 2015 after selling out during the quarter.
  • Cambria Investment Management sold 68,200 Medifast shares in Q4 2015, an estimated $1.83M.
  • Cambria Investment Management first reported a position in Medifast in Q4 2014 and held it in 4 quarters.
  • Cambria Investment Management's Medifast position peaked at $2.76M in Q2 2015.
  • 131 funds tracked by Wall St. Rank held Medifast as of Q4 2015.

Based on Cambria Investment Management's 13F filing for Q4 2015, filed 11 Feb 2016.